Track topics on Twitter Track topics that are important to you
The psychotropic effects of cannabis may be what the historically maligned drug is best known for, yet in recent decades a growing body of evidence continues to suggest that the drug has numerous valuable properties that make it a potentially valuable therapeutic. Now, investigators from NYU School of Medicine have shown in a new large-scale, randomized, controlled trial that cannabidiol (CBD)—a compound derived from the cannabis plant that does not produce a "high"—significantly reduces the number of dangerous seizures in patients with a severe form of epilepsy called Lennox-Gastaut syndrome. Findings from the new study were published recently in the New England Journal of Medicine , in an article entitled “ Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome .” "This new study adds rigorous evidence of cannabidiol's effectiveness in reducing seizure burden in a severe form of epilepsy and, importantly, is the first study of ...
Original Article: Marijuana Constituent Significantly Reduces Severe Epileptic SeizuresNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...